Signs and Symptoms: Nausea and vomiting Signs and Symptoms Nausea and vomiting
Conditions
Interventions
A single supply of commercially available ginger capsules will be purchased. Patients in the study group will receive 550mg orally 3x a day for 5 days. 1st dose will be administered 1 hour prior to
Sponsors
Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: 118 cancer patients
Exclusion criteria
Exclusion criteria: 1. Any prior chemotherapy 2. Anticipatory nausea/vomiting 3. Concurrent use of products containing ginger or ginger preparations 4. Concurrent use of any other experimental drugs 5. Clinical or radiological evidence of cerebral metastases 6. Clinical or radiological evidence of intestinal obstruction; any profound metabolic disturbance liable to cause nausea and vomiting (hypercalcaemia, diabetic ketoacidosis etc) 7. Any history of hypersensitivity to ginger 8. Any condition precluding the use of standard antiemetic therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antiemetic control (no nausea or vomiting during the study period) | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed